SCHEMBL194352

SCHEMBL194352

C=CCc1cc(C(c2ccc(OCC3CO3)c(CC=C)c2)(C(F)(F)F)C(F)(F)F)ccc1OCC1CO1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
TSHR P16473 4/20 0.38
MAPT P10636 4/20 0.38
TP53 P04637 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HPGD P15428 2/20 0.38
HIF1A Q16665 2/20 0.38
CYP1A2 P05177 1/20 0.38
PPARG P37231 1/20 0.38
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PTGDR Q13258 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
VDR P11473 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
SPHK2 Q9NRA0 1/20 0.33
THRB P10828 1/20 0.33
KDM4E B2RXH2 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12675208 0.89 MAPT (0.40) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL12736002 0.88 ALDH1A1 (0.42) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL194491 0.85 ALDH1A1 (0.52) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL15964084 0.85 ALDH1A1 (0.52) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL15215823 0.85 ALDH1A1 (0.52) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL29651825 0.85 ALDH1A1 (0.52) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL29361272 0.85 ALDH1A1 (0.52) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL20785638 0.85 ALDH1A1 (0.36) ALDH1A1TSHRMAPTTP53MEN1
SCHEMBL14591648 0.82 PTPN1 (0.34) PTGDRPTGDR2SPHK2GABRA1GABRB2
SCHEMBL15815771 0.82 ALDH1A1 (0.49) ALDH1A1TSHRMAPTTP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10850482-B2 Resin composition, resin film, semiconductor laminate, method for manufacturing semiconductor laminate, and method for manufacturing semiconductor device SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-12-01 US disclosed
US-10730273-B2 Resin composition, resin film, semiconductor laminate, method for manufacturing semiconductor laminate, and method for manufacturing semiconductor device SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-08-04 US disclosed
US-20190070836-A1 RESIN COMPOSITION, RESIN FILM, SEMICONDUCTOR LAMINATE, METHOD FOR MANUFACTURING SEMICONDUCTOR LAMINATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-03-07 US disclosed
US-20190070837-A1 RESIN COMPOSITION, RESIN FILM, SEMICONDUCTOR LAMINATE, METHOD FOR MANUFACTURING SEMICONDUCTOR LAMINATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-03-07 US disclosed
US-8378148-B2 Alcoholic hydroxyl-containing compounds and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-02-19 US disclosed
EP-2316810-B1 Alcoholic hydroxyl-containing compounds and making method SHINETSU CHEMICAL CO (JP) 2012-01-04 EP disclosed
EP-2316810-A1 Alcoholic hydroxyl-containing compounds and making method Shin-Etsu Chemical Co., Ltd. (JP) 2011-05-04 EP disclosed
US-20110082321-A1 ALCOHOLIC HYDROXYL-CONTAINING COMPOUNDS AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082321-A1 ALCOHOLIC HYDROXYL-CONTAINING COMPOUNDS AND MAKING METHOD ADH1A, ADH1C, ADH5 ALDH1A1 65/4885TSHR 2707/4885MAPT 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.